1. 2022-RA-1492-ESGO Homologous recombination deficiency (HRD): a new ovarian cancer biomarker – validation of decentralized genomic profiling, with a focus on genomic large rearrangements (LRs). (20th October 2022) Authors: Denkert, Carsten; Romey, Marcel; Swedlund, Brad; Hattesohl, Akira; Teply-Szymanski, Julia; Kommoss, Stefan; Kaiser, Kristin; Staebler, Annette; Bois, Andreas Du; Grass, Albert; Knappmeyer, Christiane; Heitz, Florian; Solimeno, Cara; Harter, Philipp; Marmé, Frederik; Gaiser, Timo; Neff, Chris; Wag... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A343 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Characterisation of homologous recombination deficiency in paired primary and recurrent high-grade serous ovarian cancer. Issue 9 (30th October 2018) Authors: Patel, Jai; Braicu, Ioana; Timms, Kirsten; Solimeno, Cara; Tshiaba, Placede; Reid, Julia; Lanchbury, Jerry; Darb-Esfahani, Silvia; Ganapathi, Mahrukh; Sehouli, Jalid; Ganapathi, Ram Journal: British journal of cancer Issue: Volume 119:Issue 9(2018) Page Start: 1060 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗